Potential risks from Hospira, Inc. power cord failure include electrical shock, delay in setup and therapy, interruption of therapy, device failure, and fires.
Continue reading...14. August 2009
Comments Off
Recalled because the affected lot may contain some tablets exceeding weight requirements which may lead to super-potent tablets.
Continue reading...14. August 2009
Comments Off
Cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept.
Continue reading...13. August 2009
Comments Off
GDH-PQQ Glucose Monitoring Technology - possibility of falsely elevated blood glucose results when using GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose test strips, which may mask significant hypoglycemia or prompt excessive insulin administration, leading to serious injury or death.
Continue reading...8. August 2009
The birth control pill Yaz is being investigated because the alleged serious side effects that are hurting women.
Continue reading...5. August 2009
Comments Off
Class 1 recall due to potential for patients experiencing under- or over-infusion, which may result in serious injury or death.
Continue reading...
17. August 2009
Comments Off